secwatch.observer — SEC 8-K summary
======================================

Issuer:     enVVeno Medical Corp (NVNO)
CIK:        0001661053
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0001493152-25-017691
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

enVVeno Medical receives Nasdaq bid-price deficiency notice; cure period to April 2026
--------------------------------------------------------------------------------

- Nasdaq notified enVVeno on Oct 7, 2025 that bid price closed below $1.00 for 30 consecutive business days.
- Company has until April 6, 2026 to regain compliance by closing at or above $1.00 for 10 consecutive trading days.
- If unmet, may seek 180-day extension by meeting other listing standards and committing to reverse stock split.
- No immediate effect on listing; stock remains on Nasdaq Capital Market pending cure or appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661053/000149315225017691/0001493152-25-017691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661053/000149315225017691/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-017691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer